Elastography: A new imaging method for evaluating scleroderma skin by Santiago, T et al.
1 Background 
Skin involvement is of major clinical and prognostic relevance in systemic sclerosis (SSc) and is often the primary outcome of clinical trials in SSc. 
Nevertheless, a fully validated, objective and sensitive measure of skin involvement is lacking.  
Shear-wave elastography in the form of Siemens’ proprietary, Virtual Touch and Imaging Quantification (VTIQ), is an emerging, operator-independent technique, 
which can obtain absolute quantitative stiffness values. 
The objective of this study was to determine validity and reliability of shear-wave elastography for measuring skin stiffness as a measure of 
skin involvement in SSc. 
2 Methods 
Ø  Patients 
       26 consenting patient with confirmed SSc (2013 classification criteria) underwent clinical evaluation and demographic data collection. 
        17 age and gender-matched healthy volunteers were recruited from the  hospital staff and patients’ family members. 
Ø  Modified Rodnan skin score (mRSS) 
        Skin thickness was clinical assessed over 17 anatomical anatomical sites 
Ø Ultrasound evaluation 
        Absolute skin stiffness (shear wave velocity, in m/s) was measured at all mRSS anatomical sites (except face)  
        Siemens ACUSON S3000TM ultrasound system with a linear 4-9MHz transducer. Sampling gates sized 2x2mm.  
        Higher shear-wave velocity value indicates higher tissue stiffness. 
Ø Reliability 
Intra-observer reliability was assessed by intraclass correlation coefficients (ICC) in 4 SSc patients at all 17 sites and 2 healthy controls, in 2 sequential scanning     
sessions, one week apart. 
Ø Statistical analysis 
Correlations between absolute skin stiffness and mRSS, and comparison between patients and controls were statistically performed using a two-tailed t–test, in SPSS 
software. P values <0.05 were considered significant. 
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a)  Shear-wave elastography represents a feasible and reproducible quantitative method for assessing stiffness in scleroderma skin 
b)   Shear-wave elastography is an innovative and promising technique that provides, for the first time, a non-invasive, absolute quantification of tissue stiffness. 
c) Further studies are needed in larger cohorts of patients with varying degrees of skin thickening, and in longitudinal studies. 
4 Discussion 
We found systematically higher absolute skin stiffness values in SSc patients than controls. 
Possible implications of shear-wave elastography:  
Ø May represent a valuable tool in quantitative assessment of skin involvement in SSc  
Ø May differentiate subclinical skin changes, ie corresponding to an mRSS of zero 
Further studies are required, but this early study supports the clinical and scientific potential of this new measure of skin involvement in SSc. 
Table 1 - Clinical features of SSc patients and controls. 
Table 2- mRSS and shear-wave velocity values (m/s) in SSc patients 
and controls. 
Ø  Absolute skin stiffness measurements were statistically  significantly higher 
in SSc than in controls, in 6 out of 9 mRSS anatomical sites of analysis 
(table 2). 
 
Ø   The ICCs for agreement between ultrasound measurements was 0.8… 
 











B - Patient 
Shear-wave elastography of the dorsal aspect of the hand. Absolute shear-
wave velocities (in m/s) within the sample gate (yellow box) are shown 
quantitatively on the right side. The color scale depicts graphically the 
absolute stiffness of all tissues within the region of interest. (red=hard tissue; 
blue=soft tissue).  
ACA, anticentromere antibodies; ANA, antinuclear antibodies; D, diffuse cutaneous SSc; L, limited 
cutaneous SSc; mRSS, modified Rodnan skin score; RP, Raynaud's Phenomenon. 
 
